Cat.#: ACPP-1734
| Despition | EFNA3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
| ACPP-1108 | Recombinant Human CD34 Protein (6×His Tag) (AC1108) | 50 µg | inquiry |
| ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
| ACPP-1815 | Human HAAO Protein (AC1815) | 2 µg | inquiry |
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.